Enseval Putera Megatrading Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enseval Putera Megatrading Tbk PT with three other
drug stores in Asia:
Hokuyaku Takeyama Holdings, Inc
sales of 227.79 billion Japanese Yen [US$2.10 billion]
of which 70%
was Pharmaceutical Business),
Guangxi Liuzhou Pharmaceutical Co Ltd
(11.71 billion Chinese Renmimbi [US$1.65 billion]
of which 87%
was Wholesale), and
Luyan Pharma Co Ltd
based in China
(11.50 billion Chinese Renmimbi [US$1.62 billion]
of which 93%
was Pharmaceutical Wholesale).
Enseval Putera Megatrading Tbk PT reported sales of 20.60 trillion Indonesian Rupiahs (US$1.46 billion)
December of 2018.
increase of 4.8%
versus 2017, when the company's sales were 19.67 trillion Indonesian Rupiahs.
Sales at Enseval Putera Megatrading Tbk PT have increased during each of the previous five years
(and since 2013, sales have increased a total of 32%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
11.3% in 2018, from
2.85 trillion Indonesian Rupiahs to 3.17 trillion Indonesian Rupiahs.